{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:13:35Z","timestamp":1781619215490,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research","doi-asserted-by":"publisher","award":["S-1439-0104"],"award-info":[{"award-number":["S-1439-0104"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.intimp.2019.01.050","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T05:05:39Z","timestamp":1550466339000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Inhibitory effect of valproate sodium on pain behavior in diabetic mice involves suppression of spinal histone deacetylase 1 and inflammatory mediators"],"prefix":"10.1016","volume":"70","author":[{"given":"Nehal M.","family":"Elsherbiny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5493-4189","authenticated-orcid":false,"given":"Ghada Abdel","family":"Kader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4327-4920","authenticated-orcid":false,"given":"Yousra","family":"Abdel-mottaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"ElSayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal M.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9688-7683","authenticated-orcid":false,"given":"Sawsan A.","family":"Zaitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.01.050_bb0005","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Toronto diabetic neuropathy expert group, diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2019.01.050_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0002-9343(99)00007-8","article-title":"Diabetic neuropathy: scope of the syndrome","volume":"107","author":"Greene","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2019.01.050_bb0015","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1098\/rstb.2009.0313","article-title":"Glial cells in neuronal network function","volume":"365","author":"Araque","year":"2010","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.intimp.2019.01.050_bb0020","first-page":"607","article-title":"Glial cells and synaptic activity: translational control of metabolic coupling","volume":"50","author":"L\u00f3pez-Bayghen","year":"2010","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrneurol.2011.84","article-title":"Pain: MAPK inhibitor shows promise in clinical trial for neuropathic pain","volume":"7","author":"Kingwell","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000323141","article-title":"p38\/MAPK inhibitor modulates the expression of dorsal horn GABA(B) receptors in the spinal nerve ligation model of neuropathic pain","volume":"18","author":"Wu","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.intimp.2019.01.050_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2016.12.001","article-title":"Histone acetylation and histone deacetylation in neuropathic pain: an unresolved puzzle?","volume":"795","author":"Khangura","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1006\/bbrc.2001.4786","article-title":"Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation","volume":"283","author":"Cai","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2019.01.050_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0050","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1526-4637.2012.01488.x","article-title":"Epigenetics and the transition from acute to chronic pain","volume":"13","author":"Buchheit","year":"2012","journal-title":"Pain Med."},{"key":"10.1016\/j.intimp.2019.01.050_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainresbull.2016.04.010","article-title":"Is there any therapeutic value for the use of histone deacetylase inhibitors for chronic pain?","volume":"125","author":"Wang","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2019.01.050_bb0060","article-title":"Histone deacetylase 5 (Hdac5) regulates neuropathic pain via Sry-related Hmg-box 10 (Sox10)-dependent mechanism in mice","volume":"1","author":"Gu","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2019.01.050_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pbb.2017.08.006","article-title":"The new HDAC1 inhibitor LG325 ameliorates neuropathic pain in a mouse model","volume":"160","author":"Sanna","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.intimp.2019.01.050_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nbd.2009.07.019","article-title":"Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo","volume":"36","author":"Faraco","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2019.01.050_bb0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1933719111424453","article-title":"Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats","volume":"19","author":"Liu","year":"2012","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.intimp.2019.01.050_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/sj.bjp.0706310","article-title":"Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain","volume":"146","author":"Winkler","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009183.pub2","article-title":"Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults","author":"Gill","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2019.01.050_bb0090","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.59.5_suppl_2.S14","article-title":"Use of anticonvulsants for treatment of neuropathic pain","volume":"59","author":"Backonja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2019.01.050_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2010.08.024","article-title":"Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures","volume":"41","author":"Gibbons","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2019.01.050_bb0100","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of Valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2019.01.050_bb0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbadis.2009.10.009","article-title":"Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice","volume":"1802","author":"Kikumoto","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.intimp.2019.01.050_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molstruc.2015.11.055","article-title":"Synthesis, structure and antidiabetic activity of chromium(III) complexes of metformin Schiff-bases","volume":"1108","author":"Mahmoud","year":"2016","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.intimp.2019.01.050_bb0115","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10973-016-6018-1","article-title":"Synthesis, spectral, thermal and insulin-enhancing properties of oxovanadium(IV) complexes of metformin Schiff-bases","volume":"128","author":"Mahmoud","year":"2017","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.intimp.2019.01.050_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.taap.2006.12.016","article-title":"Gene expression profiles of murine fatty liver induced by the administration of valproic acid","volume":"220","author":"Lee","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.intimp.2019.01.050_bb0130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.21542","article-title":"Beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain","volume":"65","author":"Yalcin","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2013.04.020","article-title":"In vitro binding affinities of a series of flavonoids for \u03bc-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3\u2011dibromoflavanone in mice","volume":"72","author":"Higgs","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2019.01.050_bb0140","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.pnpbp.2005.11.036","article-title":"The four-plates test: anxiolytic or analgesic paradigm?","volume":"30","author":"Ripoll","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2019.01.050_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.107.126052","article-title":"(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties","volume":"323","author":"Tzschentke","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2019.01.050_bb0150","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.intimp.2019.01.050_bb0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2015.12.035","article-title":"Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: influence on spinal microglia and astrocytes","volume":"771","author":"Reda","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.lfs.2018.05.025","article-title":"Neuroprotective effect of duloxetine in a mouse model of diabetic neuropathy: role of glia suppressing mechanisms","volume":"205","author":"Tawfik","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2019.01.050_bb0165","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awl217","article-title":"Remyelination is extensive in a subset of multiple sclerosis patients","volume":"129","author":"Patrikios","year":"2006","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn2606","article-title":"Animal models of pain: progress and challenges","volume":"10","author":"Mogil","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2019.01.050_bb0175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/9780470942390.mo110116","article-title":"Behavioral measures of pain thresholds","volume":"1","author":"Minett","year":"2011","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pain.2010.08.010","article-title":"Sensitized peripheral nociception in experimental diabetes of the rat","volume":"151","author":"Fuchs","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2019.01.050_bb0185","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1523\/JNEUROSCI.4866-06.2007","article-title":"Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons","volume":"27","author":"Jagodic","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2019.01.050_bb0190","doi-asserted-by":"crossref","first-page":"10785","DOI":"10.1523\/JNEUROSCI.0935-07.2007","article-title":"State-dependent enhancement of subthreshold A-type potassium current by 4\u2011aminopyridine in tuberomammillary nucleus neurons","volume":"27","author":"Jackson","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2019.01.050_bb0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/brain\/awr345","article-title":"Reduced conduction failure of the main axon of polymodal nociceptive C-fibres contributes to painful diabetic neuropathy in rats","volume":"135","author":"Sun","year":"2012","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0200","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00210-013-0853-4","article-title":"Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties","volume":"386","author":"Ximenes","year":"2013","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0205","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200060050-00005","article-title":"Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy","volume":"60","author":"Tremont-Lukats","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2019.01.050_bb0210","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918798408","article-title":"The etiological changes of acetylation in peripheral nerve injury\u2013induced neuropathic hypersensitivity","volume":"14","author":"Wang","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.intimp.2019.01.050_bb0215","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.expneurol.2004.11.001","article-title":"Immune and glial cell factors as pain mediators and modulators","volume":"192","author":"McMahon","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/exnr.1994.1165","article-title":"GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801","volume":"129","author":"Garrison","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jor.23328","article-title":"Rapamycin suppresses microglial activation and reduces the development of neuropathic pain after spinal cord injury","volume":"35","author":"Tateda","year":"2017","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.intimp.2019.01.050_bb0230","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5455\/jppa.20140702125046","article-title":"Duloxetine modulates vincristine-induced painful neuropathy in rats","volume":"4","author":"Greish","year":"2014","journal-title":"J. Physiol. Pharmacol. Adv."},{"key":"10.1016\/j.intimp.2019.01.050_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(01)01816-7","article-title":"Role of cytokines in endometriosis","volume":"76","author":"Harada","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.intimp.2019.01.050_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000097238","article-title":"Intracerebroventricular injection of tumor necrosis factor-\u03b1Induces thermal hyperalgesia in rats","volume":"3","author":"Oka","year":"1996","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.intimp.2019.01.050_bb0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0006-8993(99)01326-8","article-title":"Acute peripheral inflammation induces moderate glial activation and spinal IL-1\u03b2 expression that correlates with pain behavior in the rat1Published on the world wide web on 17 march 1999.1","volume":"829","author":"Sweitzer","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2019.01.050_bb0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(99)00450-4","article-title":"Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy","volume":"270","author":"Sommer","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2019.01.050_bb0255","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.23-07-02517.2003","article-title":"Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons","volume":"23","author":"Sch\u00e4fers","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2019.01.050_bb0260","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/35068566","article-title":"Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity","volume":"410","author":"Samad","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2019.01.050_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpain.2004.06.004","article-title":"Spinal neural cyclooxygenase-2 mediates pain caused in a rat model of lumbar disk herniation","volume":"5","author":"Ohtori","year":"2004","journal-title":"J. Pain"},{"key":"10.1016\/j.intimp.2019.01.050_bb0270","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1096\/fj.02-0101com","article-title":"IL-1\u03b2 potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C","volume":"16","author":"Obreja","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2019.01.050_bb0275","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nrd1251","article-title":"GLIA: a novel drug discovery target for clinical pain","volume":"2","author":"Watkins","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2019.01.050_bb0280","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pain.2004.02.018","article-title":"HIV-1 gp120 Stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS)","volume":"110","author":"Holguin","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2019.01.050_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00147","article-title":"Does Valproic acid have potential in the treatment of diabetes mellitus?","volume":"8","author":"Rakitin","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0290","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jdiacomp.2011.06.006","article-title":"Sympathetic neuropathy in diabetes mellitus patients does not elicit Charcot osteoarthropathy","volume":"25","author":"Christensen","year":"2011","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.intimp.2019.01.050_bb0295","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bpobgyn.2006.01.016","article-title":"Pathology and physiopathology of adenomyosis","volume":"20","author":"Bergeron","year":"2006","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0300","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbi.2017.12.030","article-title":"Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats","volume":"281","author":"Said","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2019.01.050_bb0305","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/15376516.2018.1459995","article-title":"Renoprotective effect of nifuroxazide in diabetes-induced nephropathy: impact on NF\u03baB, oxidative stress, and apoptosis","volume":"28","author":"Elsherbiny","year":"2018","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.intimp.2019.01.050_bb0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1139\/cjpp-2015-0135","article-title":"Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis","volume":"94","author":"Khodeer","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0315","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneur.1995.00540350039015","article-title":"Successful treatment of neuropathies in patients with diabetes mellitus","volume":"52","author":"Krendel","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-10-69","article-title":"Beneficial effect of TNF-\u03b1 inhibition on diabetic peripheral neuropathy","volume":"10","author":"Shi","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2019.01.050_bb0325","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1139\/cjpp-2015-0242","article-title":"Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats","volume":"94","author":"Gad","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0330","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diab.41.5.557","article-title":"The impact of diabetes on the CNS","volume":"41","author":"McCall","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2019.01.050_bb0335","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2019.01.050_bb0340","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1471-4906(03)00079-6","article-title":"Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?","volume":"24","author":"Netea","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0345","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","article-title":"IL-1 pathways in inflammation and human diseases","volume":"6","author":"Gabay","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2019.01.050_bb0350","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jfma.2013.05.013","article-title":"Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats","volume":"113","author":"Kukkar","year":"2014","journal-title":"J. Formos. Med. Assoc. Taiwan Yi Zhi."},{"key":"10.1016\/j.intimp.2019.01.050_bb0355","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918768970","article-title":"Icariin, a flavonoid with anti-cancer effects, alleviated paclitaxel-induced neuropathic pain in a SIRT1-dependent manner","volume":"14","author":"Gui","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.intimp.2019.01.050_bb0360","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s12035-017-0384-y","article-title":"The effects of histone deacetylase inhibition on the levels of cerebral cytokines in an animal model of mania induced by dextroamphetamine","volume":"55","author":"Valvassori","year":"2018","journal-title":"Mol. Neurobiol."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2023.109807","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T13:43:59Z","timestamp":1565185439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918312827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":72,"alternative-id":["S1567576918312827"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.01.050","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.intimp.2023.109807","asserted-by":"object"}]},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effect of valproate sodium on pain behavior in diabetic mice involves suppression of spinal histone deacetylase 1 and inflammatory mediators","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.01.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}